Cargando…
3, 3′-diindolylmethane Enhances the Effectiveness of Herceptin against HER-2/Neu-Expressing Breast Cancer Cells
Herceptin failure is a major clinical problem in breast cancer. A subset of breast cancer patients with high HER-2/neu levels eventually experience metastatic disease progression when treated with Herceptin as a single agent. Mechanistic details of development of this aggressive disease are not clea...
Autores principales: | Ahmad, Aamir, Ali, Shadan, Ahmed, Alia, Ali, Azfur S., Raz, Avraham, Sakr, Wael A., Rahman, KM Wahidur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551844/ https://www.ncbi.nlm.nih.gov/pubmed/23372748 http://dx.doi.org/10.1371/journal.pone.0054657 |
Ejemplares similares
-
Serological Her2/neu-determination in patients receiving Herceptin(®)
por: Thomas, A, et al.
Publicado: (2001) -
Mechanisms and Therapeutic Implications of Cell Death Induction by Indole Compounds
por: Ahmad, Aamir, et al.
Publicado: (2011) -
Recombinant humanised anti-HER2/neu antibody (Herceptin®) induces cellular death of glioblastomas
por: Mineo, J-F, et al.
Publicado: (2004) -
Plant-Made Trastuzumab (Herceptin) Inhibits HER2/Neu+ Cell Proliferation and Retards Tumor Growth
por: Komarova, Tatiana V., et al.
Publicado: (2011) -
Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results
por: Slamon, DJ
Publicado: (2000)